333 related articles for article (PubMed ID: 25146933)
1. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
2. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
3. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
[TBL] [Abstract][Full Text] [Related]
6. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
7. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
8. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
9. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
12. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH
J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441
[TBL] [Abstract][Full Text] [Related]
13. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
Wesselowski S; Gordon SG; Fries R; Saunders AB; Sykes KT; Vitt J; Boutet B; Häggström J; Kadotani S; Stack J; Barnett BG
J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
[TBL] [Abstract][Full Text] [Related]
14. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.
Cremer SE; Moesgaard SG; Rasmussen CE; Zois NE; Falk T; Reimann MJ; Cirera S; Aupperle H; Oyama MA; Olsen LH
Res Vet Sci; 2015 Jun; 100():197-206. PubMed ID: 25843893
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
16. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
17. No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response.
Reimann MJ; Faisst DN; Knold M; Meurs KM; Stern JA; Cremer SE; Møller JE; Ljungvall I; Häggström J; Olsen LH
J Vet Intern Med; 2023; 37(6):2145-2156. PubMed ID: 37743723
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
Mead SE; Beijerink NJ; O'Brien M; Wade CM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
[TBL] [Abstract][Full Text] [Related]
20. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]